References
- Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357-64
- Yazganoglu KD, Ozkaya E, Ergin-Ozcan P, Cakar N. Vancomycin- induced drug hypersensitivity syndrome. J Eur Acad Dermatol Venereol 2005;19:648-50 https://doi.org/10.1111/j.1468-3083.2005.01228.x
- Hannah BA, Kimmel PL, Dosa S, Turner ML. Vancomycininduced toxic epidermal necrolysis. South Med J 1990;83: 720-2 https://doi.org/10.1097/00007611-199006000-00035
- Forrence EA, Goldman MP. Vancomycin-associated exfoliative dermatitis. DICP 1990;24:369-71 https://doi.org/10.1177/106002809002400405
- Hsu SI. Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy 2001;21:1233-9 https://doi.org/10.1592/phco.21.15.1233.33901
- Maki DG, Bohn MJ, Stolz SM, Kroncke GM, Acher CW, Myerowitz PD. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Cardiovasc Surg 1992;104:1423-34
- Romanelli VA, Howie MB, Myerowitz PD, Zvara DA, Rezaei A, Jackman DL, et al. Intraoperative and postoperative effects of vancomycin administration in cardiac surgery patients: a prospective, double-blind, randomized trial. Crit Care Med 1993;21:1124-31 https://doi.org/10.1097/00003246-199308000-00009
- Bayer AS. Infective endocarditis. Clin Infect Dis 1993;17: 313-22 https://doi.org/10.1093/clinids/17.3.313
- Litt JZ. Drug Eruption Reference Manual 2000. New York: Parthenon Publishing Group, 2000:591-2
- Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002;8:5
- Handfield-Jones SE, Jenkins RE, Whittaker SJ, Besse CP, McGibbon DH. The anticonvulsant hypersensitivity syndrome. Br J Dermatol 1993;129:175-7 https://doi.org/10.1111/j.1365-2133.1993.tb03523.x
- Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-90 https://doi.org/10.1001/archinte.155.21.2285
- Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003;68:1781-90
- Kwon HS, Chang YS, Jeong YY, Lee SM, Song WJ, Kim HB, et al. A case of hypersensitivity syndrome to both vancomycin and teicoplanin. J Korean Med Sci 2006;21:1108-10 https://doi.org/10.3346/jkms.2006.21.6.1108
- Alqdah M, Al-Hihi E. Bullous skin eruption: A rare immune- mediated reaction to vancomycin. Chest 2006;130(3 Suppl):337S-9S
- Marius R. Drug hypersensitivity syndrome. DermNet NZ 2006. Available from:URL://http://www.dermnetnz.org/reactions/drug-hypersensitivity-syndrome.html
- Polk RE, Israel D, Wang J, Venitz J, Miller J, Stotka J. Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers. Antimicrob Agents Chemother 1993;37:2139-43 https://doi.org/10.1128/AAC.37.10.2139
- Anne S, Middleton E Jr, Reisman RE. Vancomycin anaphylaxis and successful desensitization. Ann Allergy 1994;73: 402-404
- Baden LA, Apovian C, Imber MJ, Dover JS. Vancomycininduced linear IgA bullous dermatosis. Arch Dermatol 1988; 124:1186-8 https://doi.org/10.1001/archderm.124.8.1186
- Vidal C, Gonzlez Quintela A, Fuente R. Toxic epidermal necrolysis due to vancomycin. Ann Allergy 1992;68:345-7
- Korman TM, Turnidge JD, Grayson ML. Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother 1997;39:371-81 https://doi.org/10.1093/oxfordjournals.jac.a020861